Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit

Autor: Parkar, Rosemeen, Boleti, Ekaterini
Zdroj: In Clinical Medicine March 2019 19(2) Supplement:s54-s54
Databáze: ScienceDirect